| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0027 | 1 |